Connection

CHAD CREIGHTON to Acrylamides

This is a "connection" page, showing publications CHAD CREIGHTON has written about Acrylamides.
Connection Strength

0.233
  1. Osimertinib activates a TGF-?2-dependent secretory program that drives lung adenocarcinoma progression. J Clin Invest. 2026 02 02; 136(3).
    View in: PubMed
    Score: 0.233
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.